Gefitinib 250mg

What Is Gefitinib 250mg

Gefitinib 250mg is a prescription anticancer medicine used in the treatment of non-small cell lung cancer. It is mainly given when the cancer cells have specific genetic changes that respond to targeted therapy.

This medicine belongs to a group called EGFR inhibitors (drugs that block epidermal growth factor receptor, a protein that helps cancer cells grow and divide). A medical oncologist (cancer specialist doctor) prescribes this medicine after proper diagnostic tests like genetic mutation testing.

In lung cancer, some cancer cells grow rapidly due to abnormal signals inside the body. These signals tell the cells to multiply without control.

Gefitinib 250mg works by blocking these abnormal growth signals, which helps slow down or stop cancer cell growth.

Uses of Gefitinib 250mg

Gefitinib 250mg uses are mainly focused on the treatment of lung cancer, especially in patients with specific EGFR gene mutations.

It is commonly prescribed for non-small cell lung cancer, which is one of the most frequent types of lung cancer. This medicine is usually used when the cancer has spread to other parts of the body or cannot be removed by surgery.

Doctors may recommend it as a targeted therapy, which means it acts specifically on cancer cells with certain genetic changes while having less effect on normal cells.

It helps in controlling disease progression, improving breathing symptoms, and reducing complications caused by tumor growth. In many patients, it is used as a long-term oral therapy under close medical supervision.

How Gefitinib 250mg Works

Gefitinib 250mg works by blocking the activity of the epidermal growth factor receptor (EGFR), a protein found on the surface of cells. This receptor sends signals that tell cells to grow and divide.

In some lung cancers, the EGFR becomes overactive due to genetic mutations. This leads to uncontrolled cancer cell growth.

Gefitinib attaches to this receptor and blocks its activity. When the signal is blocked, cancer cells lose their ability to multiply quickly and start to slow down or die.

In simple terms, this medicine stops cancer cells from receiving the “growth signals” they need to survive. This helps control tumor growth and slows down disease progression.

Side Effects of Gefitinib 250mg

Gefitinib 250mg side effects may occur because the medicine also affects some normal cells in the body along with cancer cells.

Common side effects include skin rash, dry skin, and acne-like eruptions. Some patients may also experience diarrhea, nausea, or mild stomach discomfort during treatment.

In some cases, loss of appetite and tiredness may occur. These effects are usually manageable with supportive care and medical guidance.

Less common but serious side effects may include lung inflammation, liver function changes, or severe skin reactions. If breathing difficulty, persistent cough, or yellowing of the skin occurs, immediate medical attention is required.

Most side effects are monitored closely by the treating oncologist during therapy.

Safety & Precautions

Gefitinib 250mg should only be used under the supervision of a medical oncologist (cancer specialist) after proper diagnostic confirmation.

Regular monitoring is important during treatment. Doctors may recommend blood tests and imaging scans to check response and detect side effects early.

Before starting this medicine, inform your doctor if you have liver disease, lung conditions, or are taking other medications, as interactions may occur.

Avoid self-adjusting the dose or stopping the medicine without medical advice, as this may affect treatment outcomes.

Patients should report any new symptoms such as breathing problems, severe diarrhea, or skin reactions to their specialist immediately.

Medical Disclaimer

This content is for educational purposes only. It does not replace medical advice, diagnosis, or treatment from a qualified medical oncologist (cancer specialist doctor). Always consult a healthcare professional before using Gefitinib 250mg or any anticancer medicine. Do not start, stop, or change any treatment without proper medical supervision.